Want to learn more?
Our forecasts mirror the realities of the marketplace so you have defendable forecasts that enable confident decision making. We have the competency and experience to deliver when precision, speed and understanding cannot be compromised.
Quantifying future potential with confidence
Forecasting, epidemiology, scientific and access teams work seamlessly to produce comprehensive, defendable forecasts.
Preparing for competitive events
Anticipate and plan for changes in diagnosis and treatment rates, new product launches and market expansion.
User-friendly models that adapt with your market
Alter assumptions and add model segments while tracking patients across disease stages or lines of therapy.
Kantar recognises the importance of rare diseases in furthering patient care and understands the inherent challenges you face. Our forecasters and epidemiologists triangulate data sources and, working with our subject matter experts, incorporate Key Opinion Leader (KOL) input to accurately size patient populations and deliver defendable forecasts.
Forecasting for cancer treatments comes with unique challenges, including determining the correct number of patients, following them through lines of therapies and addressing various biomarkers and patient segments. Our deep understanding of cancer and proprietary data solutions ensure you get a comprehensive deliverable you can trust.